{
    "Rank": 616,
    "Study": {
        "ProtocolSection": {
            "IdentificationModule": {
                "NCTId": "NCT05265429",
                "OrgStudyIdInfo": {
                    "OrgStudyId": "21-442"
                },
                "Organization": {
                    "OrgFullName": "Dana-Farber Cancer Institute",
                    "OrgClass": "OTHER"
                },
                "BriefTitle": "Biology of Young Lung Cancer Study: The YOUNG LUNG Study",
                "OfficialTitle": "Biology of Young Lung Cancer Study: The YOUNG LUNG Study"
            },
            "StatusModule": {
                "StatusVerifiedDate": "January 2023",
                "OverallStatus": "Active, not recruiting",
                "ExpandedAccessInfo": {
                    "HasExpandedAccess": "No"
                },
                "StartDateStruct": {
                    "StartDate": "January 1, 2023",
                    "StartDateType": "Actual"
                },
                "PrimaryCompletionDateStruct": {
                    "PrimaryCompletionDate": "August 1, 2027",
                    "PrimaryCompletionDateType": "Anticipated"
                },
                "CompletionDateStruct": {
                    "CompletionDate": "August 1, 2027",
                    "CompletionDateType": "Anticipated"
                },
                "StudyFirstSubmitDate": "February 16, 2022",
                "StudyFirstSubmitQCDate": "February 22, 2022",
                "StudyFirstPostDateStruct": {
                    "StudyFirstPostDate": "March 3, 2022",
                    "StudyFirstPostDateType": "Actual"
                },
                "LastUpdateSubmitDate": "January 20, 2023",
                "LastUpdatePostDateStruct": {
                    "LastUpdatePostDate": "January 23, 2023",
                    "LastUpdatePostDateType": "Actual"
                }
            },
            "SponsorCollaboratorsModule": {
                "ResponsibleParty": {
                    "ResponsiblePartyType": "Principal Investigator",
                    "ResponsiblePartyInvestigatorFullName": "Pasi Janne, MD, PhD",
                    "ResponsiblePartyInvestigatorTitle": "Principal Investigator",
                    "ResponsiblePartyInvestigatorAffiliation": "Dana-Farber Cancer Institute"
                },
                "LeadSponsor": {
                    "LeadSponsorName": "Dana-Farber Cancer Institute",
                    "LeadSponsorClass": "OTHER"
                }
            },
            "OversightModule": {
                "OversightHasDMC": "No",
                "IsFDARegulatedDrug": "No",
                "IsFDARegulatedDevice": "No"
            },
            "DescriptionModule": {
                "BriefSummary": "The purpose of this research study is to learn more about lung cancer (NSCLC or SCLC) diagnosed in adults at ages 45 or younger.",
                "DetailedDescription": "This research study looks to enroll as many people diagnosed with lung cancer at 45 years old or younger in order to:\n\nBetter understand causes of lung cancer in individuals 45 years old and younger, which is a rare disease\nBetter estimate lung cancer risks and potential risk factors for lung cancer in individuals 45 years old and younger\nExamine tumor (somatic) or normal (germline) genetic changes that may be shared among young lung cancer patients\nImprove opportunities for screening and treatment of lung cancer in individuals 45 years old and younger\n\nStudy procedures will include:\n\nCollecting information from participants' medical record and two (2) short questionnaires\nCollecting blood and/or saliva samples\nCollecting tumor tissue samples (optional)\n\nIt is expected that about 500 people will take part in this research study. Participants will be in this study until it closes or the participant withdraws consent."
            },
            "ConditionsModule": {
                "ConditionList": {
                    "Condition": [
                        "Non Small Cell Lung Cancer",
                        "Small Cell Lung Carcinoma"
                    ]
                },
                "KeywordList": {
                    "Keyword": [
                        "Non Small Cell Lung Cancer",
                        "Small Cell Lung Carcinoma",
                        "Genetics",
                        "Genomics",
                        "Young lung cancer"
                    ]
                }
            },
            "DesignModule": {
                "StudyType": "Observational",
                "PatientRegistry": "No",
                "DesignInfo": {
                    "DesignObservationalModelList": {
                        "DesignObservationalModel": [
                            "Cohort"
                        ]
                    },
                    "DesignTimePerspectiveList": {
                        "DesignTimePerspective": [
                            "Other"
                        ]
                    }
                },
                "BioSpec": {
                    "BioSpecRetention": "Samples With DNA",
                    "BioSpecDescription": "whole blood, serum, tissue"
                },
                "EnrollmentInfo": {
                    "EnrollmentCount": "500",
                    "EnrollmentType": "Actual"
                }
            },
            "ArmsInterventionsModule": {
                "ArmGroupList": {
                    "ArmGroup": [
                        {
                            "ArmGroupLabel": "Data/Biospecimen Collection",
                            "ArmGroupDescription": "Tumor and saliva specimens from participants with non-small cell lung cancer (NSCLC) or small cell lung cancer (SCLC) diagnosed at age 45 or younger",
                            "ArmGroupInterventionList": {
                                "ArmGroupInterventionName": [
                                    "Genetic: Data and Specimen Collection"
                                ]
                            }
                        }
                    ]
                },
                "InterventionList": {
                    "Intervention": [
                        {
                            "InterventionType": "Genetic",
                            "InterventionName": "Data and Specimen Collection",
                            "InterventionDescription": "Provide research team access to relevant medical records\nAnswer two (2) short questionnaires at time of consent\nProvide up to 5 tubes (37 ml) of blood at or near the time of consent, and/or saliva sample\n\nConsider consenting to other optional parts of the research such as:\n\nProviding additional blood or tissue samples in the future (optional)\nProviding permission for obtainment of stored tissue specimens from lung cancer surgeries or biopsies from the pathology departments where they have been stored (optional)",
                            "InterventionArmGroupLabelList": {
                                "InterventionArmGroupLabel": [
                                    "Data/Biospecimen Collection"
                                ]
                            }
                        }
                    ]
                }
            },
            "OutcomesModule": {
                "PrimaryOutcomeList": {
                    "PrimaryOutcome": [
                        {
                            "PrimaryOutcomeMeasure": "Repository of specimens and data",
                            "PrimaryOutcomeDescription": "Prospective registry of young lung cancer specimens for exploratory tumor and germline genomics, transcriptomics/proteomics, and future biomarker study.",
                            "PrimaryOutcomeTimeFrame": "5 years or study closure"
                        }
                    ]
                },
                "SecondaryOutcomeList": {
                    "SecondaryOutcome": [
                        {
                            "SecondaryOutcomeMeasure": "Number of patients with targetable somatic alterations in known oncogenic driver genes",
                            "SecondaryOutcomeDescription": "Targetable alterations are defined as any somatic alteration in a driver oncogene for which a Food and Drug Administration-approved therapy exists, for which an off-label therapy exists, or for which a clinical trial exists (including but not limited to EGFR, KRAS, ALK, ROS1, RET, MET, BRAF, and TRK). Results will be summarized using descriptive statistics.",
                            "SecondaryOutcomeTimeFrame": "5 years or study closure"
                        },
                        {
                            "SecondaryOutcomeMeasure": "Number of patients with predicted oncogenic alterations in unknown driver genes",
                            "SecondaryOutcomeDescription": "Unknown driver genes include genes not currently known to be driver oncogenes in lung cancer, and for which no directed treatment exists. Results will be summarized using descriptive statistics.",
                            "SecondaryOutcomeTimeFrame": "5 years or study closure"
                        },
                        {
                            "SecondaryOutcomeMeasure": "Number of patients with pathogenic or likely pathogenic germline alterations in known cancer predisposition genes",
                            "SecondaryOutcomeDescription": "Pathogenic or likely pathogenic variants based on classification by the American College of Medical Genetics and Genomics (ACMG). Results will be summarized using descriptive statistics.",
                            "SecondaryOutcomeTimeFrame": "5 years or study closure"
                        }
                    ]
                }
            },
            "EligibilityModule": {
                "EligibilityCriteria": "Inclusion Criteria:\n\nAge 45 and under at lung cancer diagnosis\nPathologically confirmed bronchogenic lung carcinoma (NSCLC or SCLC of any stage) at any treatment time point\nProvision of written informed consent\nWillingness to undergo no more than two (2) peripheral blood draws in a four (4) week period, with no more than 50 ml peripheral blood collected over eight (8) weeks\nIndividuals under age 18 are eligible for study if they meet defined criteria; in addition, consent for participation must be given by a legal guardian or parent\n\nExclusion Criteria:\n\nIndividuals who decline to sign consent\nIndividuals who are unable to give consent or assent and are without a designated healthcare proxy\nCompromise of patient diagnosis or staging if tissue is used for research",
                "HealthyVolunteers": "No",
                "Gender": "All",
                "MinimumAge": "15 Years",
                "MaximumAge": "45 Years",
                "StdAgeList": {
                    "StdAge": [
                        "Child",
                        "Adult"
                    ]
                },
                "StudyPopulation": "Adults age 45 or under at time of non-small lung cancer (NSCLC) or small cell lung cancer (SCLC) diagnosis",
                "SamplingMethod": "Probability Sample"
            },
            "ContactsLocationsModule": {
                "OverallOfficialList": {
                    "OverallOfficial": [
                        {
                            "OverallOfficialName": "Pasi A Janne, MD, PhD",
                            "OverallOfficialAffiliation": "Dana-Farber Cancer Institute",
                            "OverallOfficialRole": "Principal Investigator"
                        }
                    ]
                },
                "LocationList": {
                    "Location": [
                        {
                            "LocationFacility": "Massachusetts General Hospital",
                            "LocationCity": "Boston",
                            "LocationState": "Massachusetts",
                            "LocationZip": "02114",
                            "LocationCountry": "United States"
                        },
                        {
                            "LocationFacility": "Beth Israel Deaconess Medical Center",
                            "LocationCity": "Boston",
                            "LocationState": "Massachusetts",
                            "LocationZip": "02115",
                            "LocationCountry": "United States"
                        },
                        {
                            "LocationFacility": "Brigham and Women's Hospital",
                            "LocationCity": "Boston",
                            "LocationState": "Massachusetts",
                            "LocationZip": "02115",
                            "LocationCountry": "United States"
                        },
                        {
                            "LocationFacility": "Dana-Farber Cancer Institute",
                            "LocationCity": "Boston",
                            "LocationState": "Massachusetts",
                            "LocationZip": "02115",
                            "LocationCountry": "United States"
                        }
                    ]
                }
            },
            "IPDSharingStatementModule": {
                "IPDSharing": "Yes",
                "IPDSharingDescription": "The Dana-Farber / Harvard Cancer Center encourages and supports the responsible and ethical sharing of data from clinical trials. De-identified participant data from the final research dataset used in the published manuscript may only be shared under the terms of a Data Use Agreement. Requests may be directed to: [contact information for Sponsor Investigator or designee]. The protocol and statistical analysis plan will be made available on Clinicaltrials.gov only as required by federal regulation or as a condition of awards and agreements supporting the research.",
                "IPDSharingInfoTypeList": {
                    "IPDSharingInfoType": [
                        "Study Protocol",
                        "Statistical Analysis Plan (SAP)",
                        "Informed Consent Form (ICF)"
                    ]
                },
                "IPDSharingTimeFrame": "Data can be shared no earlier than 1 year following the date of publication",
                "IPDSharingAccessCriteria": "Contact the Belfer Office for Dana-Farber Innovations (BODFI) at innovation@dfci.harvard.edu"
            }
        },
        "DerivedSection": {
            "MiscInfoModule": {
                "VersionHolder": "September 08, 2023"
            },
            "ConditionBrowseModule": {
                "ConditionMeshList": {
                    "ConditionMesh": [
                        {
                            "ConditionMeshId": "D000008175",
                            "ConditionMeshTerm": "Lung Neoplasms"
                        },
                        {
                            "ConditionMeshId": "D000002289",
                            "ConditionMeshTerm": "Carcinoma, Non-Small-Cell Lung"
                        },
                        {
                            "ConditionMeshId": "D000055752",
                            "ConditionMeshTerm": "Small Cell Lung Carcinoma"
                        }
                    ]
                },
                "ConditionAncestorList": {
                    "ConditionAncestor": [
                        {
                            "ConditionAncestorId": "D000009369",
                            "ConditionAncestorTerm": "Neoplasms"
                        },
                        {
                            "ConditionAncestorId": "D000012142",
                            "ConditionAncestorTerm": "Respiratory Tract Neoplasms"
                        },
                        {
                            "ConditionAncestorId": "D000013899",
                            "ConditionAncestorTerm": "Thoracic Neoplasms"
                        },
                        {
                            "ConditionAncestorId": "D000009371",
                            "ConditionAncestorTerm": "Neoplasms by Site"
                        },
                        {
                            "ConditionAncestorId": "D000008171",
                            "ConditionAncestorTerm": "Lung Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000012140",
                            "ConditionAncestorTerm": "Respiratory Tract Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000002283",
                            "ConditionAncestorTerm": "Carcinoma, Bronchogenic"
                        },
                        {
                            "ConditionAncestorId": "D000001984",
                            "ConditionAncestorTerm": "Bronchial Neoplasms"
                        }
                    ]
                },
                "ConditionBrowseLeafList": {
                    "ConditionBrowseLeaf": [
                        {
                            "ConditionBrowseLeafId": "M10862",
                            "ConditionBrowseLeafName": "Lung Neoplasms",
                            "ConditionBrowseLeafAsFound": "Lung Cancer",
                            "ConditionBrowseLeafRelevance": "high"
                        },
                        {
                            "ConditionBrowseLeafId": "M28013",
                            "ConditionBrowseLeafName": "Small Cell Lung Carcinoma",
                            "ConditionBrowseLeafAsFound": "Small Cell Lung Carcinoma",
                            "ConditionBrowseLeafRelevance": "high"
                        },
                        {
                            "ConditionBrowseLeafId": "M5236",
                            "ConditionBrowseLeafName": "Carcinoma, Non-Small-Cell Lung",
                            "ConditionBrowseLeafAsFound": "Non-Small Cell Lung Cancer",
                            "ConditionBrowseLeafRelevance": "high"
                        },
                        {
                            "ConditionBrowseLeafId": "M5224",
                            "ConditionBrowseLeafName": "Carcinoma",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M14669",
                            "ConditionBrowseLeafName": "Respiratory Tract Neoplasms",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M16348",
                            "ConditionBrowseLeafName": "Thoracic Neoplasms",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M10858",
                            "ConditionBrowseLeafName": "Lung Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M14667",
                            "ConditionBrowseLeafName": "Respiratory Tract Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M5230",
                            "ConditionBrowseLeafName": "Carcinoma, Bronchogenic",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M4950",
                            "ConditionBrowseLeafName": "Bronchial Neoplasms",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "T5271",
                            "ConditionBrowseLeafName": "Small Cell Lung Cancer",
                            "ConditionBrowseLeafAsFound": "Small Cell Lung Carcinoma",
                            "ConditionBrowseLeafRelevance": "high"
                        }
                    ]
                },
                "ConditionBrowseBranchList": {
                    "ConditionBrowseBranch": [
                        {
                            "ConditionBrowseBranchAbbrev": "BC04",
                            "ConditionBrowseBranchName": "Neoplasms"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "BC08",
                            "ConditionBrowseBranchName": "Respiratory Tract (Lung and Bronchial) Diseases"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "All",
                            "ConditionBrowseBranchName": "All Conditions"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "Rare",
                            "ConditionBrowseBranchName": "Rare Diseases"
                        }
                    ]
                }
            }
        }
    }
}